Open AccessConservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study
Author(s) -
P Mazza,
George W. Moran,
Gen Li,
Dennis Robins,
Justin T. Matulay,
Harry W. Herr,
G. Joel DeCastro,
James M. McKiernan,
Christopher B. Anderson
Publication year - 2018
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.05.078
Subject(s) - medicine , cystectomy , bladder cancer , chemotherapy , cohort , neoadjuvant therapy , cancer , surgery , urology , oncology , breast cancer
We report the outcomes in patients with muscle invasive bladder cancer from 2 institutions who experienced a clinically complete response to neoadjuvant platinum based chemotherapy and elected active surveillance. It was unknown whether conservative treatment could be safely implemented in these patients.